Global In Vivo Toxicology Market 2022 by Company, Regions, Type and Application, Forecast to 2028

  • receipt Report ID : 287243
  • calendar_today Published On: Mar, 2022
  • file_copy Pages: 156
  • list Pharmaceuticals and Healthcare
Buy @ $3500

The In Vivo Toxicology market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest study, due to COVID-19 pandemic, the global In Vivo Toxicology market size is estimated to be worth US$ 4315.8 million in 2021 and is forecast to a readjusted size of USD 6215.3 million by 2028 with a CAGR of 5.3% during review period. Immunotoxicity accounting for % of the In Vivo Toxicology global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Chronic Toxicity Testing segment is altered to a % CAGR between 2022 and 2028.

Global key companies of In Vivo Toxicology include Thermo Fisher Scientific, Danaher, Charles River Laboratories, Labcorp, and The Jackson Laboratory, etc. In terms of revenue, the global top four players hold a share over % in 2021.

Market segmentation

In Vivo Toxicology market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

Chronic Toxicity Testing

Sub-Chronic Toxicity Testing

Sub-Acute Toxicity Testing

Acute Toxicity Testing

Market segment by Application, can be divided into

Immunotoxicity

Systemic Toxicity

Carcinogenicity

Genotoxicity

Developmental and Reproductive Toxicity(DART)

Other Toxicity Endpoints

Market segment by players, this report covers

Thermo Fisher Scientific

Danaher

Charles River Laboratories

Labcorp

The Jackson Laboratory

Data Sciences International

Envigo

Eurofins Scientific

Perkinelmer

SRI International

Taconic Biosciences

Wuxi Apptec

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:

Chapter 1, to describe In Vivo Toxicology product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top players of In Vivo Toxicology, with revenue, gross margin and global market share of In Vivo Toxicology from 2019 to 2022.

Chapter 3, the In Vivo Toxicology competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and In Vivo Toxicology market forecast, by regions, type and application, with revenue, from 2023 to 2028.

Chapter 11 and 12, to describe In Vivo Toxicology research findings and conclusion, appendix and data source.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Product Overview and Scope of In Vivo Toxicology

1.2 Classification of In Vivo Toxicology by Type

1.2.1 Overview: Global In Vivo Toxicology Market Size by Type: 2017 Versus 2021 Versus 2028

1.2.2 Global In Vivo Toxicology Revenue Market Share by Type in 2021

1.2.3 Chronic Toxicity Testing

1.2.4 Sub-Chronic Toxicity Testing

1.2.5 Sub-Acute Toxicity Testing

1.2.6 Acute Toxicity Testing

1.3 Global In Vivo Toxicology Market by Application

1.3.1 Overview: Global In Vivo Toxicology Market Size by Application: 2017 Versus 2021 Versus 2028

1.3.2 Immunotoxicity

1.3.3 Systemic Toxicity

1.3.4 Carcinogenicity

1.3.5 Genotoxicity

1.3.6 Developmental and Reproductive Toxicity(DART)

1.3.7 Other Toxicity Endpoints

1.4 Global In Vivo Toxicology Market Size & Forecast

1.5 Global In Vivo Toxicology Market Size and Forecast by Region

1.5.1 Global In Vivo Toxicology Market Size by Region: 2017 VS 2021 VS 2028

1.5.2 Global In Vivo Toxicology Market Size by Region, (2017-2022)

1.5.3 North America In Vivo Toxicology Market Size and Prospect (2017-2028)

1.5.4 Europe In Vivo Toxicology Market Size and Prospect (2017-2028)

1.5.5 Asia-Pacific In Vivo Toxicology Market Size and Prospect (2017-2028)

1.5.6 South America In Vivo Toxicology Market Size and Prospect (2017-2028)

1.5.7 Middle East and Africa In Vivo Toxicology Market Size and Prospect (2017-2028)

1.6 Market Drivers, Restraints and Trends

1.6.1 In Vivo Toxicology Market Drivers

1.6.2 In Vivo Toxicology Market Restraints

1.6.3 In Vivo Toxicology Trends Analysis

2 Company Profiles

2.1 Thermo Fisher Scientific

2.1.1 Thermo Fisher Scientific Details

2.1.2 Thermo Fisher Scientific Major Business

2.1.3 Thermo Fisher Scientific In Vivo Toxicology Product and Solutions

2.1.4 Thermo Fisher Scientific In Vivo Toxicology Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.1.5 Thermo Fisher Scientific Recent Developments and Future Plans

2.2 Danaher

2.2.1 Danaher Details

2.2.2 Danaher Major Business

2.2.3 Danaher In Vivo Toxicology Product and Solutions

2.2.4 Danaher In Vivo Toxicology Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.2.5 Danaher Recent Developments and Future Plans

2.3 Charles River Laboratories

2.3.1 Charles River Laboratories Details

2.3.2 Charles River Laboratories Major Business

2.3.3 Charles River Laboratories In Vivo Toxicology Product and Solutions

2.3.4 Charles River Laboratories In Vivo Toxicology Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.3.5 Charles River Laboratories Recent Developments and Future Plans

2.4 Labcorp

2.4.1 Labcorp Details

2.4.2 Labcorp Major Business

2.4.3 Labcorp In Vivo Toxicology Product and Solutions

2.4.4 Labcorp In Vivo Toxicology Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.4.5 Labcorp Recent Developments and Future Plans

2.5 The Jackson Laboratory

2.5.1 The Jackson Laboratory Details

2.5.2 The Jackson Laboratory Major Business

2.5.3 The Jackson Laboratory In Vivo Toxicology Product and Solutions

2.5.4 The Jackson Laboratory In Vivo Toxicology Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.5.5 The Jackson Laboratory Recent Developments and Future Plans

2.6 Data Sciences International

2.6.1 Data Sciences International Details

2.6.2 Data Sciences International Major Business

2.6.3 Data Sciences International In Vivo Toxicology Product and Solutions

2.6.4 Data Sciences International In Vivo Toxicology Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.6.5 Data Sciences International Recent Developments and Future Plans

2.7 Envigo

2.7.1 Envigo Details

2.7.2 Envigo Major Business

2.7.3 Envigo In Vivo Toxicology Product and Solutions

2.7.4 Envigo In Vivo Toxicology Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.7.5 Envigo Recent Developments and Future Plans

2.8 Eurofins Scientific

2.8.1 Eurofins Scientific Details

2.8.2 Eurofins Scientific Major Business

2.8.3 Eurofins Scientific In Vivo Toxicology Product and Solutions

2.8.4 Eurofins Scientific In Vivo Toxicology Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.8.5 Eurofins Scientific Recent Developments and Future Plans

2.9 Perkinelmer

2.9.1 Perkinelmer Details

2.9.2 Perkinelmer Major Business

2.9.3 Perkinelmer In Vivo Toxicology Product and Solutions

2.9.4 Perkinelmer In Vivo Toxicology Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.9.5 Perkinelmer Recent Developments and Future Plans

2.10 SRI International

2.10.1 SRI International Details

2.10.2 SRI International Major Business

2.10.3 SRI International In Vivo Toxicology Product and Solutions

2.10.4 SRI International In Vivo Toxicology Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.10.5 SRI International Recent Developments and Future Plans

2.11 Taconic Biosciences

2.11.1 Taconic Biosciences Details

2.11.2 Taconic Biosciences Major Business

2.11.3 Taconic Biosciences In Vivo Toxicology Product and Solutions

2.11.4 Taconic Biosciences In Vivo Toxicology Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.11.5 Taconic Biosciences Recent Developments and Future Plans

2.12 Wuxi Apptec

2.12.1 Wuxi Apptec Details

2.12.2 Wuxi Apptec Major Business

2.12.3 Wuxi Apptec In Vivo Toxicology Product and Solutions

2.12.4 Wuxi Apptec In Vivo Toxicology Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.12.5 Wuxi Apptec Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global In Vivo Toxicology Revenue and Share by Players (2019, 2020, 2021, and 2022)

3.2 Market Concentration Rate

3.2.1 Top 3 In Vivo Toxicology Players Market Share in 2021

3.2.2 Top 10 In Vivo Toxicology Players Market Share in 2021

3.2.3 Market Competition Trend

3.3 In Vivo Toxicology Players Head Office, Products and Services Provided

3.4 In Vivo Toxicology Mergers & Acquisitions

3.5 In Vivo Toxicology New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global In Vivo Toxicology Revenue and Market Share by Type (2017-2022)

4.2 Global In Vivo Toxicology Market Forecast by Type (2023-2028)

5 Market Size Segment by Application

5.1 Global In Vivo Toxicology Revenue Market Share by Application (2017-2022)

5.2 Global In Vivo Toxicology Market Forecast by Application (2023-2028)

6 North America by Country, by Type, and by Application

6.1 North America In Vivo Toxicology Revenue by Type (2017-2028)

6.2 North America In Vivo Toxicology Revenue by Application (2017-2028)

6.3 North America In Vivo Toxicology Market Size by Country

6.3.1 North America In Vivo Toxicology Revenue by Country (2017-2028)

6.3.2 United States In Vivo Toxicology Market Size and Forecast (2017-2028)

6.3.3 Canada In Vivo Toxicology Market Size and Forecast (2017-2028)

6.3.4 Mexico In Vivo Toxicology Market Size and Forecast (2017-2028)

7 Europe by Country, by Type, and by Application

7.1 Europe In Vivo Toxicology Revenue by Type (2017-2028)

7.2 Europe In Vivo Toxicology Revenue by Application (2017-2028)

7.3 Europe In Vivo Toxicology Market Size by Country

7.3.1 Europe In Vivo Toxicology Revenue by Country (2017-2028)

7.3.2 Germany In Vivo Toxicology Market Size and Forecast (2017-2028)

7.3.3 France In Vivo Toxicology Market Size and Forecast (2017-2028)

7.3.4 United Kingdom In Vivo Toxicology Market Size and Forecast (2017-2028)

7.3.5 Russia In Vivo Toxicology Market Size and Forecast (2017-2028)

7.3.6 Italy In Vivo Toxicology Market Size and Forecast (2017-2028)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific In Vivo Toxicology Revenue by Type (2017-2028)

8.2 Asia-Pacific In Vivo Toxicology Revenue by Application (2017-2028)

8.3 Asia-Pacific In Vivo Toxicology Market Size by Region

8.3.1 Asia-Pacific In Vivo Toxicology Revenue by Region (2017-2028)

8.3.2 China In Vivo Toxicology Market Size and Forecast (2017-2028)

8.3.3 Japan In Vivo Toxicology Market Size and Forecast (2017-2028)

8.3.4 South Korea In Vivo Toxicology Market Size and Forecast (2017-2028)

8.3.5 India In Vivo Toxicology Market Size and Forecast (2017-2028)

8.3.6 Southeast Asia In Vivo Toxicology Market Size and Forecast (2017-2028)

8.3.7 Australia In Vivo Toxicology Market Size and Forecast (2017-2028)

9 South America by Country, by Type, and by Application

9.1 South America In Vivo Toxicology Revenue by Type (2017-2028)

9.2 South America In Vivo Toxicology Revenue by Application (2017-2028)

9.3 South America In Vivo Toxicology Market Size by Country

9.3.1 South America In Vivo Toxicology Revenue by Country (2017-2028)

9.3.2 Brazil In Vivo Toxicology Market Size and Forecast (2017-2028)

9.3.3 Argentina In Vivo Toxicology Market Size and Forecast (2017-2028)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa In Vivo Toxicology Revenue by Type (2017-2028)

10.2 Middle East & Africa In Vivo Toxicology Revenue by Application (2017-2028)

10.3 Middle East & Africa In Vivo Toxicology Market Size by Country

10.3.1 Middle East & Africa In Vivo Toxicology Revenue by Country (2017-2028)

10.3.2 Turkey In Vivo Toxicology Market Size and Forecast (2017-2028)

10.3.3 Saudi Arabia In Vivo Toxicology Market Size and Forecast (2017-2028)

10.3.4 UAE In Vivo Toxicology Market Size and Forecast (2017-2028)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global In Vivo Toxicology Revenue by Type, (USD Million), 2017 VS 2021 VS 2028

Table 2. Global In Vivo Toxicology Revenue by Application, (USD Million), 2017 VS 2021 VS 2028

Table 3. Global Market In Vivo Toxicology Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)

Table 4. Global In Vivo Toxicology Revenue (USD Million) by Region (2017-2022)

Table 5. Global In Vivo Toxicology Revenue Market Share by Region (2023-2028)

Table 6. Thermo Fisher Scientific Corporate Information, Head Office, and Major Competitors

Table 7. Thermo Fisher Scientific Major Business

Table 8. Thermo Fisher Scientific In Vivo Toxicology Product and Solutions

Table 9. Thermo Fisher Scientific In Vivo Toxicology Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 10. Danaher Corporate Information, Head Office, and Major Competitors

Table 11. Danaher Major Business

Table 12. Danaher In Vivo Toxicology Product and Solutions

Table 13. Danaher In Vivo Toxicology Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 14. Charles River Laboratories Corporate Information, Head Office, and Major Competitors

Table 15. Charles River Laboratories Major Business

Table 16. Charles River Laboratories In Vivo Toxicology Product and Solutions

Table 17. Charles River Laboratories In Vivo Toxicology Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 18. Labcorp Corporate Information, Head Office, and Major Competitors

Table 19. Labcorp Major Business

Table 20. Labcorp In Vivo Toxicology Product and Solutions

Table 21. Labcorp In Vivo Toxicology Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 22. The Jackson Laboratory Corporate Information, Head Office, and Major Competitors

Table 23. The Jackson Laboratory Major Business

Table 24. The Jackson Laboratory In Vivo Toxicology Product and Solutions

Table 25. The Jackson Laboratory In Vivo Toxicology Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 26. Data Sciences International Corporate Information, Head Office, and Major Competitors

Table 27. Data Sciences International Major Business

Table 28. Data Sciences International In Vivo Toxicology Product and Solutions

Table 29. Data Sciences International In Vivo Toxicology Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 30. Envigo Corporate Information, Head Office, and Major Competitors

Table 31. Envigo Major Business

Table 32. Envigo In Vivo Toxicology Product and Solutions

Table 33. Envigo In Vivo Toxicology Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 34. Eurofins Scientific Corporate Information, Head Office, and Major Competitors

Table 35. Eurofins Scientific Major Business

Table 36. Eurofins Scientific In Vivo Toxicology Product and Solutions

Table 37. Eurofins Scientific In Vivo Toxicology Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 38. Perkinelmer Corporate Information, Head Office, and Major Competitors

Table 39. Perkinelmer Major Business

Table 40. Perkinelmer In Vivo Toxicology Product and Solutions

Table 41. Perkinelmer In Vivo Toxicology Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 42. SRI International Corporate Information, Head Office, and Major Competitors

Table 43. SRI International Major Business

Table 44. SRI International In Vivo Toxicology Product and Solutions

Table 45. SRI International In Vivo Toxicology Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 46. Taconic Biosciences Corporate Information, Head Office, and Major Competitors

Table 47. Taconic Biosciences Major Business

Table 48. Taconic Biosciences In Vivo Toxicology Product and Solutions

Table 49. Taconic Biosciences In Vivo Toxicology Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 50. Wuxi Apptec Corporate Information, Head Office, and Major Competitors

Table 51. Wuxi Apptec Major Business

Table 52. Wuxi Apptec In Vivo Toxicology Product and Solutions

Table 53. Wuxi Apptec In Vivo Toxicology Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 54. Global In Vivo Toxicology Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)

Table 55. Global In Vivo Toxicology Revenue Share by Players (2019, 2020, 2021, and 2022)

Table 56. Breakdown of In Vivo Toxicology by Company Type (Tier 1, Tier 2 and Tier 3)

Table 57. In Vivo Toxicology Players Head Office, Products and Services Provided

Table 58. In Vivo Toxicology Mergers & Acquisitions in the Past Five Years

Table 59. In Vivo Toxicology New Entrants and Expansion Plans

Table 60. Global In Vivo Toxicology Revenue (USD Million) by Type (2017-2022)

Table 61. Global In Vivo Toxicology Revenue Share by Type (2017-2022)

Table 62. Global In Vivo Toxicology Revenue Forecast by Type (2023-2028)

Table 63. Global In Vivo Toxicology Revenue by Application (2017-2022)

Table 64. Global In Vivo Toxicology Revenue Forecast by Application (2023-2028)

Table 65. North America In Vivo Toxicology Revenue by Type (2017-2022) & (USD Million)

Table 66. North America In Vivo Toxicology Revenue by Type (2023-2028) & (USD Million)

Table 67. North America In Vivo Toxicology Revenue by Application (2017-2022) & (USD Million)

Table 68. North America In Vivo Toxicology Revenue by Application (2023-2028) & (USD Million)

Table 69. North America In Vivo Toxicology Revenue by Country (2017-2022) & (USD Million)

Table 70. North America In Vivo Toxicology Revenue by Country (2023-2028) & (USD Million)

Table 71. Europe In Vivo Toxicology Revenue by Type (2017-2022) & (USD Million)

Table 72. Europe In Vivo Toxicology Revenue by Type (2023-2028) & (USD Million)

Table 73. Europe In Vivo Toxicology Revenue by Application (2017-2022) & (USD Million)

Table 74. Europe In Vivo Toxicology Revenue by Application (2023-2028) & (USD Million)

Table 75. Europe In Vivo Toxicology Revenue by Country (2017-2022) & (USD Million)

Table 76. Europe In Vivo Toxicology Revenue by Country (2023-2028) & (USD Million)

Table 77. Asia-Pacific In Vivo Toxicology Revenue by Type (2017-2022) & (USD Million)

Table 78. Asia-Pacific In Vivo Toxicology Revenue by Type (2023-2028) & (USD Million)

Table 79. Asia-Pacific In Vivo Toxicology Revenue by Application (2017-2022) & (USD Million)

Table 80. Asia-Pacific In Vivo Toxicology Revenue by Application (2023-2028) & (USD Million)

Table 81. Asia-Pacific In Vivo Toxicology Revenue by Region (2017-2022) & (USD Million)

Table 82. Asia-Pacific In Vivo Toxicology Revenue by Region (2023-2028) & (USD Million)

Table 83. South America In Vivo Toxicology Revenue by Type (2017-2022) & (USD Million)

Table 84. South America In Vivo Toxicology Revenue by Type (2023-2028) & (USD Million)

Table 85. South America In Vivo Toxicology Revenue by Application (2017-2022) & (USD Million)

Table 86. South America In Vivo Toxicology Revenue by Application (2023-2028) & (USD Million)

Table 87. South America In Vivo Toxicology Revenue by Country (2017-2022) & (USD Million)

Table 88. South America In Vivo Toxicology Revenue by Country (2023-2028) & (USD Million)

Table 89. Middle East & Africa In Vivo Toxicology Revenue by Type (2017-2022) & (USD Million)

Table 90. Middle East & Africa In Vivo Toxicology Revenue by Type (2023-2028) & (USD Million)

Table 91. Middle East & Africa In Vivo Toxicology Revenue by Application (2017-2022) & (USD Million)

Table 92. Middle East & Africa In Vivo Toxicology Revenue by Application (2023-2028) & (USD Million)

Table 93. Middle East & Africa In Vivo Toxicology Revenue by Country (2017-2022) & (USD Million)

Table 94. Middle East & Africa In Vivo Toxicology Revenue by Country (2023-2028) & (USD Million)

List of Figures

Figure 1. In Vivo Toxicology Picture

Figure 2. Global In Vivo Toxicology Revenue Market Share by Type in 2021

Figure 3. Chronic Toxicity Testing

Figure 4. Sub-Chronic Toxicity Testing

Figure 5. Sub-Acute Toxicity Testing

Figure 6. Acute Toxicity Testing

Figure 7. In Vivo Toxicology Revenue Market Share by Application in 2021

Figure 8. Immunotoxicity Picture

Figure 9. Systemic Toxicity Picture

Figure 10. Carcinogenicity Picture

Figure 11. Genotoxicity Picture

Figure 12. Developmental and Reproductive Toxicity(DART) Picture

Figure 13. Other Toxicity Endpoints Picture

Figure 14. Global In Vivo Toxicology Market Size, (USD Million): 2017 VS 2021 VS 2028

Figure 15. Global In Vivo Toxicology Revenue and Forecast (2017-2028) & (USD Million)

Figure 16. Global In Vivo Toxicology Revenue Market Share by Region (2017-2028)

Figure 17. Global In Vivo Toxicology Revenue Market Share by Region in 2021

Figure 18. North America In Vivo Toxicology Revenue (USD Million) and Growth Rate (2017-2028)

Figure 19. Europe In Vivo Toxicology Revenue (USD Million) and Growth Rate (2017-2028)

Figure 20. Asia-Pacific In Vivo Toxicology Revenue (USD Million) and Growth Rate (2017-2028)

Figure 21. South America In Vivo Toxicology Revenue (USD Million) and Growth Rate (2017-2028)

Figure 22. Middle East and Africa In Vivo Toxicology Revenue (USD Million) and Growth Rate (2017-2028)

Figure 23. In Vivo Toxicology Market Drivers

Figure 24. In Vivo Toxicology Market Restraints

Figure 25. In Vivo Toxicology Market Trends

Figure 26. Thermo Fisher Scientific Recent Developments and Future Plans

Figure 27. Danaher Recent Developments and Future Plans

Figure 28. Charles River Laboratories Recent Developments and Future Plans

Figure 29. Labcorp Recent Developments and Future Plans

Figure 30. The Jackson Laboratory Recent Developments and Future Plans

Figure 31. Data Sciences International Recent Developments and Future Plans

Figure 32. Envigo Recent Developments and Future Plans

Figure 33. Eurofins Scientific Recent Developments and Future Plans

Figure 34. Perkinelmer Recent Developments and Future Plans

Figure 35. SRI International Recent Developments and Future Plans

Figure 36. Taconic Biosciences Recent Developments and Future Plans

Figure 37. Wuxi Apptec Recent Developments and Future Plans

Figure 38. Global In Vivo Toxicology Revenue Share by Players in 2021

Figure 39. In Vivo Toxicology Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021

Figure 40. Global Top 3 Players In Vivo Toxicology Revenue Market Share in 2021

Figure 41. Global Top 10 Players In Vivo Toxicology Revenue Market Share in 2021

Figure 42. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)

Figure 43. Global In Vivo Toxicology Revenue Share by Type in 2021

Figure 44. Global In Vivo Toxicology Market Share Forecast by Type (2023-2028)

Figure 45. Global In Vivo Toxicology Revenue Share by Application in 2021

Figure 46. Global In Vivo Toxicology Market Share Forecast by Application (2023-2028)

Figure 47. North America In Vivo Toxicology Sales Market Share by Type (2017-2028)

Figure 48. North America In Vivo Toxicology Sales Market Share by Application (2017-2028)

Figure 49. North America In Vivo Toxicology Revenue Market Share by Country (2017-2028)

Figure 50. United States In Vivo Toxicology Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 51. Canada In Vivo Toxicology Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 52. Mexico In Vivo Toxicology Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 53. Europe In Vivo Toxicology Sales Market Share by Type (2017-2028)

Figure 54. Europe In Vivo Toxicology Sales Market Share by Application (2017-2028)

Figure 55. Europe In Vivo Toxicology Revenue Market Share by Country (2017-2028)

Figure 56. Germany In Vivo Toxicology Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 57. France In Vivo Toxicology Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 58. United Kingdom In Vivo Toxicology Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 59. Russia In Vivo Toxicology Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 60. Italy In Vivo Toxicology Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 61. Asia-Pacific In Vivo Toxicology Sales Market Share by Type (2017-2028)

Figure 62. Asia-Pacific In Vivo Toxicology Sales Market Share by Application (2017-2028)

Figure 63. Asia-Pacific In Vivo Toxicology Revenue Market Share by Region (2017-2028)

Figure 64. China In Vivo Toxicology Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 65. Japan In Vivo Toxicology Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 66. South Korea In Vivo Toxicology Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 67. India In Vivo Toxicology Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 68. Southeast Asia In Vivo Toxicology Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 69. Australia In Vivo Toxicology Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 70. South America In Vivo Toxicology Sales Market Share by Type (2017-2028)

Figure 71. South America In Vivo Toxicology Sales Market Share by Application (2017-2028)

Figure 72. South America In Vivo Toxicology Revenue Market Share by Country (2017-2028)

Figure 73. Brazil In Vivo Toxicology Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 74. Argentina In Vivo Toxicology Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 75. Middle East and Africa In Vivo Toxicology Sales Market Share by Type (2017-2028)

Figure 76. Middle East and Africa In Vivo Toxicology Sales Market Share by Application (2017-2028)

Figure 77. Middle East and Africa In Vivo Toxicology Revenue Market Share by Country (2017-2028)

Figure 78. Turkey In Vivo Toxicology Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 79. Saudi Arabia In Vivo Toxicology Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 80. UAE In Vivo Toxicology Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 81. Methodology

Figure 82. Research Process and Data Source

shopping_cart License Type

Buy Now

email Quick Contact

tag_faces Our Clients

help Need Help?

Please contact directly on our US and India numbers

+1-201-465-4211

Please feel free to write an email to us or to use our electronic ticketing system.

sales@marketsandresearch.biz